In the past week, ALLR stock has gone up by 2.22%, with a monthly decline of -19.30% and a quarterly plunge of -76.30%. The volatility ratio for the week is 6.74%, and the volatility levels for the last 30 days are 12.75% for Allarity Therapeutics Inc The simple moving average for the past 20 days is -4.99% for ALLR’s stock, with a -97.69% simple moving average for the past 200 days.
Is It Worth Investing in Allarity Therapeutics Inc (NASDAQ: ALLR) Right Now?
The 36-month beta value for ALLR is also noteworthy at 0.41. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ALLR is 0.94M, and at present, short sellers hold a 19.09% of that float. The average trading volume of ALLR on November 15, 2024 was 565.89K shares.
ALLR) stock’s latest price update
Allarity Therapeutics Inc (NASDAQ: ALLR) has seen a decline in its stock price by -2.13 in relation to its previous close of 1.41. However, the company has experienced a 2.22% gain in its stock price over the last five trading sessions. businesswire.com reported 2024-11-12 that LOS ANGELES–(BUSINESS WIRE)–ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
ALLR Trading at -28.12% from the 50-Day Moving Average
After a stumble in the market that brought ALLR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.79% of loss for the given period.
Volatility was left at 12.75%, however, over the last 30 days, the volatility rate increased by 6.74%, as shares sank -20.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -72.22% lower at present.
During the last 5 trading sessions, ALLR rose by +2.12%, which changed the moving average for the period of 200-days by -99.49% in comparison to the 20-day moving average, which settled at $1.4524. In addition, Allarity Therapeutics Inc saw -99.58% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ALLR
Current profitability levels for the company are sitting at:
- -221.46 for the present operating margin
- 0.89 for the gross margin
The net margin for Allarity Therapeutics Inc stands at -172.73. The total capital return value is set at -1.91. Equity return is now at value -121.82, with -52.54 for asset returns.
Currently, EBITDA for the company is -12.08 million with net debt to EBITDA at 0.99. When we switch over and look at the enterprise to sales, we see a ratio of -147.82. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.01.
Conclusion
In summary, Allarity Therapeutics Inc (ALLR) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
